Cabaletta Bio (CABA) Exchange Rate Effect (2024 - 2025)
Cabaletta Bio's quarterly Exchange Rate Effect came in at -$8000.0 in Q4 2025, up 60.0% year-on-year from -$5000.0 in Q4 2024, and up 27.27% quarter-over-quarter from -$11000.0 in Q3 2025.
Cabaletta Bio has reported Exchange Rate Effect for 2 years, with the latest figure at -$8000.0 in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect rose 60.0% year-over-year to -$8000.0; the trailing twelve-month figure through Dec 2025 stood at $19000.0 (up 195.0% YoY), and the FY2025 full-year result was $19000.0, up 195.0% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at -$8000.0, up from -$11000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $31000.0 in Q2 2025, with the low at -$20000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | -8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | -20,000.00 |
| Dec 31, 2024 | -20,000.00 |